Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine.

Mice treated with IL-1β showed at seven and 14 days post treatment a lower luciferase activity but this trend did not reach statistical significance.

also in 111,027 other papers